AXT INC
No SEC Form 4 filings for $AXTI in the last 30 days.
AXT Inc (NASDAQ: AXTI) shares rose about 18.6% after the company announced semiconductor capacity expansion tied to AI demand. The article cites Q2 revenue of $47.6M (vs $18.0M a year earlier) and adjusted EPS of $0.19. It also reports Q3 guidance EPS $0.30–$0.32 and revenue about $66M, plus analyst target updates.
AXT (AXTI) shares rose nearly 10% after its July 30 earnings and have doubled to about $75.17. The article cites Q3 guidance of about $66M revenue and non-GAAP EPS $0.30 to $0.32, plus long-term supply prepayments totaling tens of millions. It highlights export-permit timing risk and a valuation near 47x forward earnings.
AXT Inc. (NASDAQ: AXTI) says an affiliate, Leblanc Living Trust, plans to sell up to 2,000 Class A shares on or about 08/07/2026 via broker Purshe Kaplan Sterling. The filing values the planned sale at about $175,020.00. A prior sale of 500 shares on 06/10/2026 generated $44,705.07.
Over the past 7 days, alphai's AI scored 9 news stories mentioning AXTI (AXT INC). Coverage has skewed bullish: 6 bullish, 2 neutral, and 1 bearish.
Recent AXTI coverage spans financial news, earnings and market movers.
The disclosed earnings inflection and sharply raised Q3 outlook are likely to sustain momentum trading, but valuation and volatility raise pullback risk.
The article frames AXTIs post-earnings rally as a permit-and-capacity execution bet, with near-term upside tied to export-permit timing and revenue clearing the guided $66M floor.
A small, disclosed insider-adjacent selling plan via Form 144, likely more of a liquidity overhang signal than a fundamental change.
The move is framed as earnings follow-through plus AI/data-center optical connectivity demand momentum, not a new discrete announcement today.
AXT’s wafer shipments are exposed to China export-permit timing, which can swing revenue and margins depending on licensing outcomes.
alphai scores every news story that mentions AXTI with an AI model for sentiment and relevance, and aggregates insider trades from AXT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
AXT Inc (NASDAQ: AXTI) shares rose about 18.6% after the company announced semiconductor capacity expansion tied to AI demand. The article cites Q2 revenue of $47.6M (vs $18.0M a year earlier) and adjusted EPS of $0.19. It also reports Q3 guidance EPS $0.30–$0.32 and revenue about $66M, plus analyst target updates.
6 min readAXT (AXTI) shares rose nearly 10% after its July 30 earnings and have doubled to about $75.17. The article cites Q3 guidance of about $66M revenue and non-GAAP EPS $0.30 to $0.32, plus long-term supply prepayments totaling tens of millions. It highlights export-permit timing risk and a valuation near 47x forward earnings.
7 min readAXT Inc. (NASDAQ: AXTI) says an affiliate, Leblanc Living Trust, plans to sell up to 2,000 Class A shares on or about 08/07/2026 via broker Purshe Kaplan Sterling. The filing values the planned sale at about $175,020.00. A prior sale of 500 shares on 06/10/2026 generated $44,705.07.
2 min readAXT, Inc. (AXTI) shares rose 15.2% as investors continued to reprice the stock after its late-July earnings breakout, according to Quiver PriceTracker. The article cites Q2 2026 revenue of $47.6M, GAAP gross margin of 44.9%, and GAAP net income of $11.1M ($0.17/share), plus management commentary on AI data-center optical connectivity demand. It also notes $412.2M cash and a $550M common-stock offering.
4 min readThe article says AI optics supply is constrained by China-controlled export licensing for indium-phosphide wafers used in data-center lasers. Lumentum (LITE) agreed to pay AXT (AXTI) $87M for six years of wafer supply, but AXT’s shipments depend on permits from Beijing’s Ministry of Commerce. It cites Reuters on possible FCC rules limiting Chinese optical transceivers and notes large stock swings for LITE, COHR, and AAOI.
7 min readSimply Wall St reports AXT (AXTI) Q2 2026 results, citing record indium phosphide revenue linked to AI data center demand and new long-term supply deals with Lumentum, Coherent, and Casella. The stock surged, with 7-day return of 85.58% and YTD return of 309.37%. The article contrasts a $96.50 fair value narrative with a $68.61 close and notes export-permit delays and China customer concentration risks.
7 min readThe article says U.S. lawmakers urged Apple to avoid using CXMT and YMTC memory chips in China-only devices. It also cites CHIPS Act incentives totaling $874 million for seven AI and HPC semiconductor firms, and DOT changes granting Zoox a temporary autonomous-vehicle exemption. It reports Apple Q3 EPS $2.02 vs $1.89, and Amazon Q2 revenue $200.61B vs $196.46B, EPS $5.75 vs $1.82, plus multiple other company earnings and guidance updates.
5 min readAXT (AXTI) reported strong Q2 results with record revenue, profit, and net income, citing high demand for indium phosphide substrates used in AI datacenter infrastructure. The company expanded capacity and expects continued multi-year demand, supported by three supply agreements. The article notes the stock is up despite being below its all-time high.
3 min readInvesting.com’s Wall Street analyst recap covers Huntington Bancshares (BofA cuts to Neutral, PT $18.50), Clorox (Jefferies cuts to Hold, expects FY27 guidance ~6% below consensus), Ribbon Communications (B. Riley upgrades to Buy, PT $3.30), New Oriental Education (Macquarie keeps Neutral, PT up 15% citing $500M capital returns), and AXT (Needham upgrades to Buy, PT $90).
6 min readAXT (AXTI) held its Q2 2026 earnings call, reporting revenue of $47.6M, up 77% vs Q1 2026 and 164% vs Q2 2025. Indium phosphide revenue was $30.7M. Non-GAAP gross margin was 45.0%. Non-GAAP net profit was $11.9M ($0.19/share). Cash rose to $749M after a $632M secondary offering. The company also discussed supply prepayments and a plan to list its Tongmei subsidiary via Hong Kong instead of China’s STAR Market.
6 min read
